Abstract: This paper presents the technical outcomes of a multimodal diagnostic assessment conducted during the PROMISE Advanced School in Malta. Attendees of the school utilized a suite of ...

But Trump himself seems stuck in history, as he is taking U.S.-China policy back to the engagement policy found in the 1990s and early 2000s. He has put commerce in the foreground and security in the ...

A shift in the way advanced triple-negative breast cancer is treated may be on the horizon with mounting evidence that moving sacituzumab govitecan, an antibody-drug conjugate (ADC), to the first line ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

A new injectable drug called amivantamab is showing real promise for people with advanced head and neck cancers that haven't responded to other treatments. At the 2026 American Society of Clinical ...

As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a ...

A cancer treatment delivered through a simple injection eliminated tumours in some patients and significantly shrank them in others during an international clinical trial involving people with ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options. This novel approach, ...